Joshua Paul
Papers
1
Total Citations
7
H-Index
1
About
Dr. Joshua Paul is a surgical innovator at the forefront of urologic oncology and regenerative biomaterials. His primary research focuses on developing advanced haemostatic agents for use in robot-assisted radical prostatectomy (RARP), with a particular emphasis on preserving the neurovascular bundle (NVB) to improve functional outcomes for patients. His landmark observational study, "A transparent synthetic peptide hydrogel as a haemostatic agent in athermal nerve sparing robot-assisted radical prostatectomy," has garnered 7 citations and represents a critical step in translating biomaterial science into the operating room. Dr. Paul's work addresses a pressing clinical need: achieving effective, athermal haemostasis without compromising delicate nerve structures during robotic surgery. By introducing a transparent, synthetic peptide hydrogel that can be prepared intraoperatively by the surgical assistant, he has opened new avenues for research into topical haemostatic agents that maintain surgical visibility and tissue preservation. His contributions bridge the gap between materials engineering and surgical practice, offering a promising pathway to reduce postoperative complications and enhance recovery. Dr. Paul’s research continues to shape the future of nerve-sparing techniques in minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1